Clinical Trial Update: Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration [NA]

View source ↗

Summary

Clinical trial update on evaluating a simplified Treat-and-Extend regimen with ranibizumab for exudative age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Mie University | Conditions: Exudative Age-related Macular Degeneration | NA | Status: UNKNOWN